Investigation of a novel DNase of Streptococcus suis serotype 2

被引:43
作者
Fontaine, MC [1 ]
Perez-Casal, J [1 ]
Willson, PJ [1 ]
机构
[1] Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK S7N 5E3, Canada
关键词
D O I
10.1128/IAI.72.2.774-781.2004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A secreted nuclease, SsnA, was identified in the virulent Streptococcus suis isolate SX332 and subsequently in each of the type strains of capsular serotypes 1 through 9. Screening of 258 porcine clinical isolates from surface (nasal mucosa or palatine tonsil) or internal (Joint, brain or other internal organ) locations revealed a significant relationship (P < 0.001) between expression of nuclease and isolation from an internal site. A 3,126-bp gene, ssnA, was identified from a phenotypically nuclease-negative pGh9:ISS1 insertion mutant, and analysis of the predicted SsnA sequence revealed a 35-amino-acid (aa) secretion signal sequence, a 22-aa DNA-binding domain, and a typical gram-positive cell wall sorting motif. A requirement of Ca2+ and Mg2+ for SsnA activity was determined, and the substrate specificity was found to be for single- and double-stranded linear DNA. Reverse transcription-PCR experiments revealed that ssnA is expressed throughout all stages of S. suis growth, and Western blots with porcine anti-S. suis immune sera against a recombinant, truncated SsnA derivative (rSsnA(Delta)) confirmed that SsnA is expressed in vivo. Furthermore, anti-rSsnA(Delta) antibodies were sufficient to neutralize SsnA activity. Analyses of subcellular fractions of SX332 and derived mutants, on DNA-containing polyacrylamide gels and by Western blotting, suggest that SsnA is cell wall located.
引用
收藏
页码:774 / 781
页数:8
相关论文
共 47 条
[1]   Generation and characterization of a defined mutant of Streptococcus suis lacking suilysin [J].
Allen, AG ;
Bolitho, S ;
Lindsay, H ;
Khan, S ;
Bryant, C ;
Norton, P ;
Ward, P ;
Leigh, J ;
Morgan, J ;
Riches, H ;
Eastty, S ;
Maskell, D .
INFECTION AND IMMUNITY, 2001, 69 (04) :2732-2735
[2]  
Alouf J.E., 1991, SOURCEBOOK BACTERIAL, P147
[3]  
AYOUB EM, 1962, PEDIATRICS, V29, P527
[4]   Role of Mycoplasma penetrans endonuclease P40 as a potential pathogenic determinant [J].
Bendjennat, M ;
Blanchard, A ;
Loutfi, M ;
Montagnier, L ;
Bahraoui, E .
INFECTION AND IMMUNITY, 1999, 67 (09) :4456-4462
[5]  
Berthelot-Hérault F, 2000, VET RES, V31, P473, DOI 10.1051/vetres:2000133
[7]   HIGH-EFFICIENCY GENE INACTIVATION AND REPLACEMENT SYSTEM FOR GRAM-POSITIVE BACTERIA [J].
BISWAS, I ;
GRUSS, A ;
EHRLICH, SD ;
MAGUIN, E .
JOURNAL OF BACTERIOLOGY, 1993, 175 (11) :3628-3635
[8]   Streptococcus suis serotype 2 mutants deficient in capsular expression [J].
Charland, N ;
Harel, J ;
Kobisch, M ;
Lacasse, S ;
Gottschalk, M .
MICROBIOLOGY-SGM, 1998, 144 :325-332
[9]   STREPTOCOCCUS-SUIS MENINGITIS [J].
CHAU, PY ;
HUANG, CY ;
KAY, R .
MEDICAL JOURNAL OF AUSTRALIA, 1983, 1 (09) :414-417
[10]   DETECTION OF STAPHYLOCOCCAL NUCLEASE ELABORATED DURING LETHAL INFECTIONS IN MICE [J].
CHESBRO, W ;
WALKER, R .
INFECTION AND IMMUNITY, 1972, 6 (06) :1028-&